Tag: Patent

Posted on

AstraZeneca Loses US Patent on Asthma Drug – IBTimes.co.uk


IBTimes.co.uk

AstraZeneca Loses US Patent on Asthma Drug
IBTimes.co.uk
Apotex and Actavis had received approval from the US Food and Drugs Administration (FDA), but they are yet to launch generic versions of the medicine, which is used to control and prevent asthma symptoms in children aged between 12 months to 8 years.
US court blow for AstraZeneca on asthma drugEvening Standard
AstraZeneca to contest US court ruling over asthma medicineIFA Magazine
AstraZeneca loses US drug patent judgmentFinancial Times
Bloomberg –GlobalPost
all 17 news articles »

View full post on asthma – Google News

Posted on

India revokes patent for Merck asthma drug – Economic Times


Economic Times

India revokes patent for Merck asthma drug
Economic Times
NEW DELHI: India has revoked a patent for an asthma drug held by US-based Merck following a challenge from local pharmaceutical giant Cipla, marking a new blow to global drug firms in the Indian market. The development is the latest in a string of …
India revokes patent on Merck asthma drugPMLiVE
Merck loses patent for asthma drugThe Hindu
India Revokes Patent on Merck Asthma Drug -ReutersAutomated Trader

all 33 news articles »

View full post on asthma – Google News

Posted on

MediciNova Receives a Notice of European Patent Allowance for Treating … – NASDAQ

MediciNova Receives a Notice of European Patent Allowance for Treating …
NASDAQ
MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis …
MediciNova Receives Notice of European Patent Allowance for Treating …Benzinga

all 3 news articles »

View full post on asthma – Google News

Posted on

Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 … – DigitalJournal.com (press release)

Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 …
DigitalJournal.com (press release)
A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory …

and more »

View full post on asthma – Google News

Posted on

Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 … – PR Newswire (press release)

Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 …
PR Newswire (press release)
A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory …

and more »

View full post on asthma – Google News